Cargando…

Comprehensive analysis of metabolic pathway activity subtypes derived prognostic signature in hepatocellular carcinoma

OBJECTIVE: Metabolic reprogramming is one of the hallmarks of cancer, but metabolic pathway activity‐related subtypes of hepatocellular carcinoma (HCC) have not been identified. METHODS: Based on the quantification results of 41 metabolic pathway activities by gene set variation analysis, the traini...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huo, Junyu, Cai, Jinzhen, Wu, Liqun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9844627/ https://www.ncbi.nlm.nih.gov/pubmed/35651292 http://dx.doi.org/10.1002/cam4.4858

Ejemplares similares

A Ferroptosis and Pyroptosis Molecular Subtype-Related Signature Applicable for Prognosis and Immune Microenvironment Estimation in Hepatocellular Carcinoma
por: Huo, Junyu, et al.
Publicado: (2021)

Integrated analysis of 1804 samples of six centers to construct and validate a robust immune-related prognostic signature associated with stromal cell abundance in tumor microenvironment for gastric cancer
por: Huo, Junyu, et al.
Publicado: (2022)

Development and Validation of a Metabolic-related Prognostic Model for Hepatocellular Carcinoma
por: Huo, Junyu, et al.
Publicado: (2021)

Construction and Validation of a Reliable Six-Gene Prognostic Signature Based on the TP53 Alteration for Hepatocellular Carcinoma
por: Huo, Junyu, et al.
Publicado: (2021)

Development and validation of a CTNNB1‐associated metabolic prognostic model for hepatocellular carcinoma
por: Huo, Junyu, et al.
Publicado: (2020)

Identification of immune infiltration-related genes as prognostic indicators for hepatocellular carcinoma
por: Dai, Kunfu, et al.
Publicado: (2022)

Eight-gene metabolic signature related with tumor-associated macrophages predicting overall survival for hepatocellular carcinoma
por: Huo, Junyu, et al.
Publicado: (2021)

Identification and validation of a five-gene prognostic signature for hepatocellular carcinoma
por: Yang, Huibin, et al.
Publicado: (2021)

A Prognostic Model of 15 Immune-Related Gene Pairs Associated With Tumor Mutation Burden for Hepatocellular Carcinoma
por: Huo, Junyu, et al.
Publicado: (2020)

Development and Validation of a Novel Immune-Gene Pairs Prognostic Model Associated with CTNNB1 Alteration in Hepatocellular Carcinoma
por: Huo, Junyu, et al.
Publicado: (2020)

Identification and validation of a novel immune-related signature associated with macrophages and CD8 T cell infiltration predicting overall survival for hepatocellular carcinoma
por: Huo, Junyu, et al.
Publicado: (2021)

Development and Validation of a Robust Immune-Related Prognostic Signature for Gastric Cancer
por: Huo, Junyu, et al.
Publicado: (2021)

A Five-Gene Signature Associated With DNA Damage Repair Molecular Subtype Predict Overall Survival for Hepatocellular Carcinoma
por: Huo, Junyu, et al.
Publicado: (2022)

Real-world systemic sequential therapy with regorafenib for recurrent hepatocellular carcinoma: analysis of 93 cases from a single center
por: Zhu, Qingwei, et al.
Publicado: (2023)

Novel Prognostic Signatures of Hepatocellular Carcinoma Based on Metabolic Pathway Phenotypes
por: Ye, Tingbo, et al.
Publicado: (2022)

Development and Validation of a Novel Metabolic-Related Signature Predicting Overall Survival for Pancreatic Cancer
por: Huo, Junyu, et al.
Publicado: (2021)

Construction and Validation of a Universal Applicable Prognostic Signature for Gastric Cancer Based on Seven Immune-Related Gene Correlated With Tumor Associated Macrophages
por: Huo, Junyu, et al.
Publicado: (2021)

Identification of novel lactate metabolism signatures and molecular subtypes for prognosis in hepatocellular carcinoma
por: Guan, Qiutong, et al.
Publicado: (2022)

Prognostic and Immunological Significance of the Molecular Subtypes and Risk Signatures Based on Cuproptosis in Hepatocellular Carcinoma
por: Tang, Xiaolong, et al.
Publicado: (2023)

An immune subtype-related prognostic signature of hepatocellular carcinoma based on single-cell sequencing analysis
por: Xie, Jiaheng, et al.
Publicado: (2022)

Comprehensive Analysis of Histone Modifications in Hepatocellular Carcinoma Reveals Different Subtypes and Key Prognostic Models
por: Li, Huikai, et al.
Publicado: (2022)

Identification of molecular subtypes and prognostic signatures based on transient receptor potential channel-related genes to predict the prognostic risk of hepatocellular carcinoma: A review
por: Wu, Dongyang, et al.
Publicado: (2023)

Genomic Instability of Mutation-Derived Gene Prognostic Signatures for Hepatocellular Carcinoma
por: Song, Ze-Bing, et al.
Publicado: (2021)

Comprehensive analysis reveals a metabolic ten-gene signature in hepatocellular carcinoma
por: Zhu, Zhipeng, et al.
Publicado: (2020)

Analysis of cuproptosis in hepatocellular carcinoma using multi-omics reveals a comprehensive HCC landscape and the immune patterns of cuproptosis
por: Li, Xinqiang, et al.
Publicado: (2022)

Identification of molecular subtypes and prognostic signature for hepatocellular carcinoma based on genes associated with homologous recombination deficiency
por: Lin, Hongsheng, et al.
Publicado: (2021)

Molecular subtypes, prognostic and immunotherapeutic relevant gene signatures mediated by DNA methylation regulators in hepatocellular carcinoma
por: Shi, Rongfeng, et al.
Publicado: (2022)

Regulatory T-cells-related signature for identifying a prognostic subtype of hepatocellular carcinoma with an exhausted tumor microenvironment
por: Zhang, Genhao
Publicado: (2022)

Construction and validation of a prognostic signature using CNV-driven genes for hepatocellular carcinoma
por: Bian, Jin, et al.
Publicado: (2021)

Tumor metabolism and associated serum metabolites define prognostic subtypes of Asian hepatocellular carcinoma
por: Pomyen, Yotsawat, et al.
Publicado: (2021)

Metabolism reprogramming signature associated with stromal cells abundance in tumor microenvironment improve prognostic risk classification for gastric cancer
por: Huo, Junyu, et al.
Publicado: (2022)

Exploration and validation of a novel prognostic signature based on comprehensive bioinformatics analysis in hepatocellular carcinoma
por: Wang, Xiaofei, et al.
Publicado: (2020)

A Comprehensive Prognostic and Immunological Analysis of a New Three-Gene Signature in Hepatocellular Carcinoma
por: Liu, Jun, et al.
Publicado: (2021)

Hepatocellular carcinoma subtypes based on metabolic pathways reveals potential therapeutic targets
por: He, Zehua, et al.
Publicado: (2023)

Identification of a prognostic signature of nine metabolism-related genes for hepatocellular carcinoma
por: Tang, Chaozhi, et al.
Publicado: (2020)

Development and Validation of a Metabolic Gene-Based Prognostic Signature for Hepatocellular Carcinoma
por: Weng, Jialei, et al.
Publicado: (2021)

Prognostic Implication of a Novel Metabolism-Related Gene Signature in Hepatocellular Carcinoma
por: Yuan, Chaoyan, et al.
Publicado: (2021)

Establishment and validation of a cholesterol metabolism-related prognostic signature for hepatocellular carcinoma
por: Tang, Linsong, et al.
Publicado: (2022)

Identification of DNA repair gene signature and potential molecular subtypes in hepatocellular carcinoma
por: Bai, Yi, et al.
Publicado: (2023)

A Prognostic Gene Signature for Hepatocellular Carcinoma
por: Chen, Rong, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_83g13hl7g12ct0meetu0m6lmon